Podcasts about HIV

Valentina is a young, gender fluid, gay crossdress and she called in to talk all about it. Tune in to hear all the details including how he identifies and why, how and why he got onto low dose hormones and how they effected him both mentally and physically, the guys that hit on her when he's dressed up as Valentina, how and when he found out he was HIV positive, how he got it and how he got to the point he was undetectable, what being undetectable means and how that works, the medication he takes and how it helps him, how he revels he is undetectable in all his hook up profiles, how and why he got into fisting, how he's been to bathhouses and what he enjoys doing there, the most men he's ever been with at same time experience and exactly what went down, the crazy other stuff he's into is plus a whole lot more **To see HOT pics of my female guests + hear anonymous confessions + get all the episodes early and AD FREE, join my Patreon! It's only $7 a month and you can cancel at any time. You can sign up here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.patreon.com/StrictlyAnonymousPodcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and when you join, I'll throw in a complimentary link to my private Discord! MY BOOK IS NOW OUT FOR PRE-ORDER!!!! Strictly Anonymous Confessions: Secret Sex Lives of Total Strangers. A bunch of short, super sexy, TRUE stories. GET YOUR COPY NOW: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://amzn.to/4i7hBCd⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠   To join SDC and get a FREE Trial! click here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.sdc.com/?ref=37712⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or go to SDC.com and use my code 37712   Want to be on the show? Email me at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠strictlyanonymouspodcast@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.strictlyanonymouspodcast.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and click on "Be on the Show" Have something quick you want to confess while remaining anonymous? Call the CONFESSIONS hotline at 347-420-3579. You can call 24/7. All voices are changed.   Sponsors:  ⁠https://brooklynbedding.com⁠⁠ Use my promo code STRICTLY at checkout to get 30% off sitewide ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://vb.health⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ To get 10% off Drive Boost by VB Health use code: STRICTLY ⁠⁠⁠⁠⁠⁠⁠https://beducate.me/pd2528-anonymous⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Use code: ANONYMOUS to get 50% off your yearly pass plus get a 14-day money-back guarantee ⁠⁠⁠⁠⁠⁠https://uberlube.com/discount/Strictly⁠⁠⁠⁠⁠⁠ Use code: STRICTLY for 10% off Uberlube aka the BEST Lube EVER ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bluechew.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Get your first month of the new Blewchew Max FREE! use code: STRICTLYANON ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://viia.co/STRICTLYANON⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Try VIIA and use code STRICTLYANON for great SEX and sleep ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://butterwellness.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Use the code “STRICTLY” at checkout for 20% off your entire order To get $15 OFF your female oxytocin arousal tablets and more, use code STRICTLY here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://shamelesscare.sjv.io/xLQ3Jv⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow me! Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/strictanonymous/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Twitter ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/strictanonymous?lang=en⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.strictlyanonymouspodcast.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

From Perplexity A.I.   A close look at the facts about Kaposi's Sarcoma may cause a major shift in the AIDS PARADIGM. If autopsy studies—such as those reported by George Hensley—found that nearly all AIDS patients show internal Kaposi's Sarcoma (KS) lesions, yet not all such patients test positive for HHV-8 (Human Herpesvirus 8), this discrepancy fundamentally challenges the prevailing theory that HHV-8 is the sole and necessary causal agent for KS in AIDS. Evidence from Autopsy Studies Hensley's team found KS-like lesions in about 95% of AIDS autopsies, far exceeding the clinical diagnosis rate and implying KS is almost universal internally among AIDS patients. These autopsies revealed a broad morphologic spectrum and inflammatory variants of KS present in nearly all risk groups, independent of external symptoms. HHV-8 Positivity is Not Universal The scientific literature overwhelmingly associates HHV-8 with most cases of KS, detecting viral DNA in a majority of lesions. However, case reports and pathology studies document KS-like tumors in HIV-positive patients that are negative for HHV-8 by immunohistochemistry—a finding dubbed “atypical spindled endothelial proliferation,” with classic histologic and clinical features still matching KS. This existence of HHV-8-negative KS challenges the central paradigm tying KS causation strictly to HHV-8, especially when these lesions are indistinguishable from those found in HHV-8-positive patients. Implications for the Role of HHV-8 If widespread KS lesions occur in AIDS patients regardless of HHV-8 status, it raises questions about the sufficiency and necessity of HHV-8 for KS pathogenesis. The data suggest that either: KS can arise independently of HHV-8, possibly due to immune dysfunction, chronic inflammation, or exposure to other infectious or environmental agents, or Current HHV-8 detection methods may miss variants or low-level infections, or that HHV-8 acts in concert with other pathogenic factors, not alone. This challenges therapeutic and diagnostic practices that rely solely on HHV-8 as a biomarker or causal link and opens a line of inquiry: Are there alternative mechanisms or cofactors in KS development—particularly in the unique immunological milieu of AIDS? Overall, the autopsy data and reports of HHV-8 negative KS suggest that the role of HHV-8 in Kaposi's Sarcoma—especially in the context of AIDS—is not as clear-cut or exclusive as often assumed. This demands a re-examination of KS pathogenesis in immunosuppressed populations and a more nuanced model that allows for multiple contributing factors.

Rebecca Culshaw Smith's Substack, “The Real AIDS Epidemic,” highlights core criticisms of mainstream HIV/AIDS theory, medical testing, pharmaceutical practices, and challenges to scientific orthodoxy. Based on her popular posts, interviews, and thematic content, these are 20 of the most important ideas advanced on her platform: 1. Questioning the existence of HIV as a unique virus, arguing that classic virological isolation (Koch's postulates) has not been fulfilled. 2. Highlighting the non-specificity and cross-reactivity of HIV antibody tests, leading to potential misdiagnosis. 3. Criticism of “viral load” PCR tests for not detecting whole pathogens but only RNA fragments. 4. Noting the shifting criteria for HIV test positivity over time, calling diagnostic standards into question. 5. Documenting long-term “non-progressors” and “elite controllers” who remain healthy without antiretroviral therapy. 6. Raising awareness of AIDS-defining illnesses in HIV-negative individuals and questioning causality. 7. Arguing that hazard from AIDS medications (e.g., AZT, Truvada, Prep) may outweigh their benefits, especially due to their toxicity and inconsistent trial results. 8. Critique of the marketing and deployment of pre-exposure prophylaxis (Prep), calling it a pharmaceutical “scandal” targeting people not at significant risk. 9.Exploring how COVID-19 public health narratives mirror what she views as deception and fear tactics from the AIDS era. 10. Disputing the epidemiological narrative that AIDS is globally caused by a single infectious agent, and highlighting massive regional/demographic inconsistencies. 11. Exposing groupthink, censorship, and reputational shaming used against scientists questioning the HIV/AIDS paradigm. 12. Emphasizing failures of antiretroviral therapy in preventing disease progression for many patients. 13.. Explaining the statistical and mathematical problems in foundational HIV/AIDS research and the “shaky foundation” of guiding studies. 14. Arguing that AIDS-defining diseases may often reflect toxicity, malnutrition, or existing comorbidities, not a distinct viral syndrome. 15. Linking historical and social factors (such as drug use, pharmaceutical incentives) to the creation and persistence of the HIV/AIDS establishment. 16. Alerting readers to issues of false positive antenatal screening and broader concerns about mass diagnostic testing in medicine. 17. Suggesting that “virus-like particles” in the body  are misidentified as pathogens, not proof of HIV's existence. 18. Forecasting that advances in AI and technology may help overturn scientific “consensus” by increasing transparency and debate. 19 Publicly refuting hit pieces and attempts to “cancel” her work as ideological suppression, not science. 20.Advocating for a return to fundamental scientific rigor and genuine skepticism in medical research, especially around virology and public health narratives. These topics synthesize her core objections to HIV/AIDS orthodoxy and frame her Substack as a point of dissent and critique against modern medical paradigms and their social consequences.

Here is an expanded, multi-act play dramatizing the philosophical conflict and personal effort to foster a paradigm shift in AIDS research. The Paradigm Shift: A Play in Three Acts Here are the three Characters Rebecca Culshaw – Mathematician and critic of AIDS orthodoxy Karl Popper – Philosopher of science, logic-driven Thomas Kuhn – Philosopher of science, historically minded The Colleague – A skeptical scientist (optional for Act II-III) Act I – The Summoning Setting: Culshaw's cluttered study at midnight. A window is open, letting in a cold breeze. Culshaw is hunched over papers. Suddenly, mysterious figures materialize. Popper (stepping closer): Rebecca, do you know why we have come? Culshaw (startled but curious): I sense you bear advice. Kuhn (smiling softly): Your struggle echoes in the halls of scientific history. Few have challenged entrenched paradigms and lived to see the world change. Culshaw: The AIDS narrative is unyielding. Criticism draws scorn, not reasoned dialogue. How do I crack this shell? Popper: Treat the theory as a scientific hypothesis. Identify its core claims. What would it take to disprove them? Ask the establishment this at every turn. Kuhn: Yet do not forget, paradigm shifts require more than refutation. You must nurture a community—make them feel the cracks and offer a new framework. Popper: Truth is not a popularity contest, Kuhn. Kuhn: But consensus rules until new puzzles make the old vision unbearable. Culshaw: You mean I need both: a demonstration of failure and a replacement vision? Popper & Kuhn (together): Precisely. Fade out. Act II – Testing the Fortress Setting: A scientific conference. Culshaw stands before a skeptical audience, including The Colleague. Culshaw: Suppose key HIV tests predict nothing about immune decline. Suppose AIDS definitions are shifting sands. What, then, does our theory become? Colleague: You twist anomalies into attacks. What of the millions of lives believed saved? Popper: (now imagined at her shoulder) Demand evidence. Show that lives were saved by measurable intervention, not just by post hoc rationalization. Kuhn: Frame your findings as questions that the current theory cannot answer. Let the audience witness the struggle. Culshaw: Here are cases where test and disease do not align, where drugs harm, where predictions fail. This is not a collection of quirks—it is a crisis. Colleague: Science will patch these gaps. Popper: Only if the patches themselves are testable—not ad hoc excuses. Kuhn: And as the failures accumulate and the story loses coherence, your role shifts. Offer new lenses through which researchers can view their puzzles anew. Culshaw: I will. Here is a framework where immune collapse arises from multifactor exposures, not a virus. Here predictions become clear, testable, vulnerable to refutation. Colleague (uncertain): It is bold, but is it enough? Popper: Make it falsifiable. Kuhn: Make it irresistible. Fade to black. Act III – Turning the Tide The Setting: Culshaw's study, months later. She pores over data. Papers about her new model are being discussed worldwide. Popper: Are your ideas withstanding scrutiny? Culshaw: Some have tried to refute them. Some admit their theories don't predict as well. Kuhn: Is a community embracing the new framework? Culshaw: Slowly. Some see the anomaly pattern. Some consider new research. The old guard resists—naturally. Popper: The measure is not in popularity, but precision. Do not shy from critique. Kuhn: And always tend to the new paradigm's coherence. Invite others to build upon it. A real shift is communal. Culshaw: Thank you, Karl. Thank you, Thomas. Let science decide—through rigor, vision, and openness—not through the chill of consensus alone. Popper and Kuhn fade, their voices echoing: Popper: Progress thrives on falsification. Kuhn: And transformation blooms with imagination. Culshaw, alone, presses onward, her desk now a beacon among the cluttered battleground of ideas. End.  

Want to dive deeper into topics like this? Master your journey with Physician Empowerment's Masterclass Membership—your gateway to exclusive content, expert-led sessions, and actionable strategies to elevate your personal and financial well-being. Learn more and join us today! https://www.physempowerment.ca/masterclass—In this episode, Dr. Wing Lim welcomes psychiatrist and real estate investor Dr. Kola Kolawole to Physician's Empowerment to discuss his career and entrepreneurship journey. Dr. Kolawole was born and educated in Nigeria and trained in psychiatry in the UK before settling in Canada over 14 years ago. As both a general and forensic psychiatrist, working primarily in forensic mental health, he values the fulfillment of helping patients with complex mental health and legal challenges. His entrepreneurship in real estate has given him diverse income streams and taught him the benefits of continuous education.Dr. Lim and Dr. Kolawole talk about how Kola was inspired in the realm of passive income by his entrepreneurial mother and gained early exposure to real estate in Nigeria. Having expanded his real estate investing in the UK, Dr. Kolawole continued building a multifamily real estate portfolio in Canada while simultaneously maintaining his medical career. Wing and Kola discuss the asset-class framework, the benefits of real estate, and they trade entrepreneurship tips. Dr. Kolawole advises physicians with limited time to invest passively through partnership or established vehicles. He suggests starting small, acquiring knowledge through courses, mentorship, and groups like Physician Empowerment to build gradually. About Dr. Kola Kolawole: Kola Kolawole, MD FRCPC, is a specialist physician, entrepreneur, educator, and lifelong learner with over 20 years of experience and expertise in healthcare, real estate investing, and asset management.Dr. Kolawole is Chair of the Board of Directors for Liberty for Youth and part of the Forensic Psychiatry Institute at St. Joseph's Healthcare Hamilton. He has authored journal articles on “Psychosocial well-being of patients with breast cancer following surgical treatment in Northern Nigeria” for BMC Psychiatry and “Psychological distress, coping strategies, and social support among HIV positive patients in Calabar, Nigeria” for the Annals of Clinical and Biomedical Research.__Physician Empowerment: Attend an upcoming Empowerment RetreatJoin the Physician Empowerment Masterclass nowWebsite: PhysEmpowerment.caDr. Kola Kolawole:ForensicPsychiatryInstitute.comLibertyForYouth.org Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Kenneth Cole is an American designer and social activist who believes that business and philanthropy are interdependent. His company, Kenneth Cole Productions, creates modern footwear, clothing, and accessories that are distributed worldwide. Kenneth's commitment to public health initiatives goes back decades. He has been one of the leading and loudest voices in the global response to HIV and AIDS for more than 30 years. Kenneth joined amfAR's board of directors in 1987 and assumed its chairmanship in 2004. Under his leadership of 14 years, amfAR was instrumental in significant breakthroughs in HIV and AIDS research, treatment, and helping to designate the disease. Since 2016, Kenneth has also been a UNAIDS International Goodwill Ambassador using his passion, insights, and vast experience to help end the public health crisis. Dori Berinstein is a six-time Tony-winning Broadway producer and an Emmy-award-winning director/producer. As a filmmaker, Dori's work includes:Dori's award-winning documentary work includes: “A Man with Sole: The Impact of Kenneth Cole”, “ShowBusiness: The Road To Broadway” (IDA Finalist), “Carol Channing: Larger Than Life” (NYT – Favorite Films of the Century) “Marvin Hamlisch: What He Did For Love” (Emmy Award) and “Gotta Dance”. Dori is Executive Producer of Isaac Mizrahi's “Unzipped”, “Liza: A Truly Terrific Absolutely True Story” and producer of Ryan Murphy's Netflix film “The Prom”, adapted from Dori's Broadway Musical (Golden Globe Nominee).  Learn more about your ad choices. Visit podcastchoices.com/adchoices

Professor Yvonne Gilleece, Honorary Clinical professor in HIV medicine & Chair of the British HIV Association, discusses the need for a HIV Action Plan in Ireland.

A potential functional cure for HIV could be just months away from human trials. Dr. Lanna reveals how her company Sentcell is using cellular rejuvenation to eliminate HIV reservoirs—and the surprising anti-aging benefits that come with it.n this groundbreaking interview, Dr. Lanna, founder and CEO of Sentcell, explains how his team has developed a revolutionary approach to HIV treatment that could eliminate the need for lifelong antiretroviral therapy. Unlike traditional strategies that target the virus directly, Sentcell's method uses a molecule called DOS to rejuvenate CD4 T-cells, triggering them to naturally clear HIV DNA from their own genomes through a process that mimics elite controllers—rare individuals who can suppress HIV without medication. The treatment works by reactivating dormant cellular pathways that outcompete HIV's integration machinery, effectively reversing viral integration and clearing infected cells within days to weeks. Beyond HIV, Dr. Lanna discusses his team's discovery of "rivers of telomeres"—vesicle structures released by rejuvenated T-cells that can systemically rejuvenate other organs and extend lifespan by 12-17 months in animal studies. With Phase 1 human trials planned for 2026 at University College London, this research represents a potential paradigm shift from managing HIV as a chronic condition to achieving a functional cure.

‘Towards a National Action Plan for HIV in Ireland' is a conference that is taking place today and tomorrow in Dublin.So, how is HIV handled in Ireland currently? And what can we maybe learn from other countries?Joining guest host Ciara Doherty to discuss is Rebecca Tallon de Havilland, who is a trans woman and HIV-positive advocate, Professor Jane Anderson, who is an AIDS Specialist and Consultant Physician at Homerton Hospital in Hackney and Stephen O'Hare, Executive Director of HIV Ireland.

Over ten years ago, in a bathroom of a swanky stranger's apartment in downtown Los Angeles, strung out and afraid, I looked up and whispered: “God, I need help.” That moment became the turning point. On June 23, 2015, I put down meth, in August, cannabis, and September 23, alcohol and every other substance. I haven't picked them up since. A decade later, I'm celebrating ten continuous years of sobriety. In this episode, I take you through the journey: the years of relapse and secrecy, the love and loss of my first partner, the shadow of HIV stigma and IV drug use, and the long climb into recovery. Inspired by the interview styles of Terry Gross (Fresh Air) and Sam Fragoso (Talk Easy), I answer six deeply personal questions (AI-Generated) about addiction, queerness, creativity, grief, and what remains unfinished ten years in. This isn't just a story about staying sober. It's about what sobriety has carved within me. A canyon of stillness, a river of resilience, and a practice of presence, peace and contentment. For anyone listening who is struggling with their own relationship to substances, whether it's meth or wine, cannabis or cocaine, you don't have to do this alone. There is a path forward. There is peace.

How does fatigue help protect our bodies, and why does it matter for athletes? Can understanding evolutionary biology improve training and recovery? In this episode, Dr. Daniel Boullosa and Dr. Olli Tikkanen discuss the science of fatigue, performance optimization, and personalized training strategies. Dr. Boullosa explains how different types of athletes respond to endurance and strength exercises, highlighting the role of warm-ups in improving muscle activation. They explore the evolutionary function of fatigue as a protective mechanism and its impact on motivation, performance, and recovery. The conversation also covers how elite athletes manage training loads and recovery in sports like professional football, where intense match schedules leave little room for traditional training. Dr. Boullosa shares insights from his research on clinical populations, investigating the effects of physical activity on conditions such as depression, hypertension, and HIV. This episode provides valuable knowledge for researchers, coaches, and athletes looking to enhance performance while minimizing injury risks. Tune in to learn how evolutionary science and personalized training approaches can optimize both sports and clinical outcomes. _   This podcast episode is sponsored by Fibion Inc. | Better Sleep, Sedentary Behavior and Physical Activity Research with Less Hassle --- Collect, store and manage SB and PA data easily and remotely - Discover ground-breaking Fibion SENS --- Learn more about Fibion Flash - a versatile customizable tool with HRV and accelerometry capability.  --- SB and PA measurements, analysis, and feedback made easy. Learn more about Fibion Research. --- Fibion Helix – Ideal for large scale studies. Scalable and affordable with patented precision. --- Fibion G2 – validated data on sitting, standing, activity types, energy expenditure, with participant friendly reports.   --- Learn more about Fibion Sleep and Fibion Circadian Rhythm Solutions. --- Fibion Kids - Activity tracking designed for children. --- Explore our Wearables, Experience sampling method (ESM), Sleep, Heart rate variability (HRV), Sedentary Behavior and Physical Activity article collections for insights on related articles. --- Refer to our article "Physical Activity and Sedentary Behavior Measurements" for an exploration of active and sedentary lifestyle assessment methods. --- Learn about actigraphy in our guide: Exploring Actigraphy in Scientific Research: A Comprehensive Guide. --- Gain foundational ESM insights with "Introduction to Experience Sampling Method (ESM)" for a comprehensive overview. --- Explore accelerometer use in health research with our article "Measuring Physical Activity and Sedentary Behavior with Accelerometers ". --- For an introduction to the fundamental aspects of HRV, consider revisiting our Ultimate Guide to Heart Rate Variability. --- Follow the podcast on Twitter https://twitter.com/PA_Researcher  Follow host Dr Olli Tikkanen on Twitter https://twitter.com/ollitikkanen  Follow Fibion on Twitter https://twitter.com/fibion  Check our YouTube channel: https://www.youtube.com/@PA_Researcher 

Send us a textJess and Traci are four hours into a Friday night when they decide to go full-send on Netflix's new documentary aka Charlie Sheen. Pour a drink and settle in: we chat the coke, the meltdowns, the infamous “tiger blood” era, and the jaw-dropping personal revelations — yes, the ice-cube anecdote, the Apocalypse Now near-fatal set story, our takes on exes like Denise Richards and Brooke Mueller, and our sudden, suspiciously intense obsession with Sean Penn. It's the wild ride of a life built on excess, fame, and some truly baffling choices — and somehow, by the end, we love him even more.We call in our pod kitty Bryn, welcome an unexpected guest, and catch up with one of our OG PodCats, Tonia. Tune in for the laughs, the cringe, and a “Would you rather…” that gets unapologetically ridiculous.Cheers

Tune into this podcast from Dr Clíona Ní Cheallaigh to learn how to provide person-centered care for treatment-experienced people with HIV. Gain strategies to address each individual's specific history and needs while considering the potential impact of comorbidities and other health challenges. Topics covered include:Individualizing Antiretroviral Regimens for Treatment-Experienced People With HIVStrategies to Improve Adherence and Addressing Barriers to Engagement in CarePerson-Centered, Trauma-Informed CareResistance Testing in the Setting of Virologic FailureSelection of ARVs With a Failing RegimenPresenters:Clíona Ní Cheallaigh, MB, MRCP, PhDConsultant PhysicianInclusion Health ServicesSt James's Hospital DublinAssociate ProfessorDepartment of MedicineTrinity College DublinDublin, IrelandLink to full program:https://bit.ly/4oiYxExGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This week on Health Lab, we showcase a recent study that examines the trends in use of pre-exposure prophylaxis, or PrEP, HIV-prevention medication. suggest more effort is needed to boost consistent use. Read the full article on our website.Episode TranscriptFor more on this story and for others like it, visit the Health Lab website where you can subscribe to our Health Lab newsletters to receive the latest in health research and information to your inbox each week. Health Lab is a part of the Michigan Medicine Podcast Network, and is produced by the Michigan Medicine Department of Communication. You can listen to Health Lab wherever you get your podcasts.All Health Lab content including health news, best practices and research insights are for informational purposes only and are not a substitute for professional medical guidance. Always seek the advice of a health care provider for questions about your health and treatment options. Hosted on Acast. See acast.com/privacy for more information.

厚生労働省、東京都千代田区厚生労働省は２６日、２０２４年に判明したエイズウイルス感染者とエイズ患者の確定値が計９９４人だったと発表した。 The combined number of people newly found to be infected with HIV and new AIDS patients in Japan in 2024 rose by 34 from the previous year to 994, up for the second straight year, the health ministry said Friday.

The rapture did not happen like predicted. Rover is keeping an open mind about God. Charlie Sheen documentary. Jim Florentine believes straight men don't get HIV. 

The rapture did not happen like predicted. Rover is keeping an open mind about God. Charlie Sheen documentary. Jim Florentine believes straight men don't get HIV. See omnystudio.com/listener for privacy information.

A new HIV prevention drug will be made available at a lower cost in over 100 low-income countries within two years, including across Africa. It's a move expected to give millions access to the breakthrough treatment and potentially bring the world closer to ending the HIV/Aids epidemic. So, how affordable and effective is it? Also, Zimbabwe continues on a quest to become Africa's blueberry capital after recently signing a tariff free export agreement with China, one of the largest consumers of the fruit. What impact will it have on the country? And why students in Europe are learning Hausa, a language spoken by millions of people in West AfricaPresenter: Charles Gitonga Producers: Yvette Twagiramariya and Patrcia Whitehorne in London. Madina Maishanu in Abuja. Technical Producer: Chris Ablakwa Senior Journalists: Sunita Nahar and Karnie Sharp Editors: Andre Lombard, Samuel Murunga, Maryam Abdalla and Alice Muthengi

This month, we're talking about an infrequently discussed, but quite powerful, implement we have in our clinical toolkit for optimizing patient outcomes: our ears. HIV/sexual health physician, researcher, and author Rageshri Dhairyawan, M.B.B.S., FRCP, joins the pod to talk about the nuances of hearing our patients — i.e., listening to them, understanding and acknowledging their concerns, and incorporating it all into HIV care provision in a way that improves their long-term health and keeps them engaged in care.   Please support us by visiting the episode transcript on TheBodyPro: https://www.thebodypro.com/podcast/hiv/future-hiv-care-listening-patients-rageshri-dhairyawan-sep-2025   Our team: This podcast is hosted by Myles Helfand; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; our associate production manager is Maui Voskova; our audio editor is Kim Buikema; and our executive producer is Myles Helfand.  

A nova diretriz da ESC/EAS 2025 em Dislipidemia chegou para mudar a forma como conduzimos nossos pacientes. O documento reforça o uso de escores na estratificação de risco, define metas de LDL ainda mais agressivas e traz para a linha de frente novas armas terapêuticas como o ácido bempedoico, o evinacumabe e o icosapent etílico.No episódio, Fernanda Justo e Raphael Rossi recebem Fernanda Del Castanhel para uma discussão prática e direta sobre:Como aplicar as novas metas de LDL em muito alto, alto, moderado e baixo risco.O papel dos fatores modificadores de risco que podem reclassificar o paciente.As novidades das terapias combinadas e o impacto dos estudos recentes como CLEAR Outcomes, IMPROVE-IT, PACMAN-AMI e HUYGENS.O que fazer em cenários especiais como HIV e pacientes oncológicos em uso de antraciclina.Minutagem:(01:50) - Como é feita a classificação e avaliação cardiovascular conforme a nova diretriz da ESC(14:15) - O que fazer com pacientes que tenham score de risco intermediário?(18:00) - O que fazer com o a "LPAzinha"?(21:30) - Quais são os novos alvos terapêuticos?(23:35) - Novidades na terapia terapia hipocolesterolemiante?(33:50) - Manejo hipolipemiante no paciente com SCA?(38:44) - Quais as atualizações no tratamento da hipertrigliceridemia?(43:40) - Novidades no tratamento do paciente com HIV(47:35) - Novidades no tratamento do paciente com neoplasia_____________________________Assine agora! Revisões didáticas de Cardiologia, semanalmente na DozeNews PRIME: a maneira mais leve e rápida de se manter atualizado(a), através do link dozeporoito.com/prime

Send us a textMeet Atlantis Narcisse, a trailblazing force in Houston's LGBTQ+ community whose journey spans decades of service, advocacy, and community building. From organizing HIV testing sessions in her living room during the 1990s epidemic to founding multiple organizations supporting transgender individuals of color, Atlantis embodies the spirit of compassionate leadership and resilient advocacy.As founder and CEO of Save Our Sisters United, Atlantis created a lifeline for transgender women seeking safe healthcare alternatives to dangerous "street hormones." Her home, lovingly called the House of Capri, became a sanctuary where LGBTQ+ individuals rejected by their birth families could find genuine acceptance. "To be that house mother was to help take care of your real life," Atlantis explains, "not your club life, not anything else but your real life and to see you as a person and empower you."The conversation takes a powerful turn when Atlantis discusses her nomination as Pride Grand Marshal, a recognition that deeply moved her as a Black trans woman over 50 in Texas. When addressing this year's theme "You won't break our pride," her response resonates with unwavering determination: "We are resilient. We are not going anywhere. Though you may take these superficial attacks at us, we are stronger and we are even stronger together." Her words reflect the ethos behind her newest initiative, Queens of Houston, a groundbreaking coalition providing unified emergency response for LGBTQ+ Houstonians during crises from hate crimes to natural disasters.Atlantis's story reveals how community strength emerges through unity and mutual support. "This is not a me fight, this is a we fight," she reminds us, highlighting how LGBTQ+ communities have historically created their own safety nets when traditional systems fail them. Her leadership demonstrates that real change happens when we recognize our collective power and stand together against challenges that might otherwise break us individually.Discover how one woman's commitment to "filling the gaps" has transformed countless lives and strengthened an entire community. Listen now to be inspired by this remarkable change-maker whose work reminds us that pride is ultimately about resilience, visibility, and the courage to create the support systems we all deserve.Queer Voices airs in Houston Texas on 90.1FM KPFT and is heard as a podcast here. Queer Voices hopes to entertain as well as illuminate LGBTQ issues in Houston and beyond. Check out our socials at:https://www.facebook.com/QueerVoicesKPFT/ andhttps://www.instagram.com/queervoices90.1kpft/

We head to Adelaide for the HIV and sexual health conference from the Australasian Society of HIV Medicine or ASHM. Ella from the Kirby Institute discusses the intersection of HIV with culturally and linguistically diverse communities. We also hear from Larisa and Carla from UNSW about the Stigma Indicators Monitoring Project for people living with HIV. Lastly, Dr Rona Carroll from the University Of Otago Wellington speaks about gender affirming care in general practice in New Zealand. Check out our other JOY Podcasts for more on LGBTIQ+ health and wellbeing at joy.org.au/wellwellwell. If there's something you'd like us to explore on the show, send through ideas or questions at wellwellwell@joy.org.au Find out more about LGBTIQ+ services and events in Victoria and South Australia at thorneharbour.org and samesh.org.au.

Russia hits back at the US President Donald Trump, after he called the nation a 'paper tiger'. The Kremlin spokesman Dmitry Peskov said 'Russia is generally associated with a bear. There are no paper bears. Russia is a real bear.' We unpack the importance of words in the US-Russia relationship and whether President Trump's comments will have any impact on the ground in Ukraine. As Syria's interim President, Ahmed Al Sharaa, addresses the United Nations General Assembly, Syrians in Damascus give us their opinion. Also: Super Typhoon Ragasa causes chaos in southern China, a landmark deal to slash the price of injectable HIV prevention drugs, and a breakthrough in treating Huntington's disease. Plus: Denmark's prime minister apologises to the victims of a forced contraceptive programme in Greenland and Jimmy Kimmel's late night show returns to our screens, after being suspended by ABC. The Global News Podcast brings you the breaking news you need to hear, as it happens. Listen for the latest headlines and current affairs from around the world. Politics, economics, climate, business, technology, health – we cover it all with expert analysis and insight.Get the news that matters, delivered twice a day on weekdays and daily at weekends, plus special bonus episodes reacting to urgent breaking stories. Follow or subscribe now and never miss a moment.Get in touch: globalpodcast@bbc.co.uk

Syria's interim president has told the UN General Assembly that his country has reclaimed its "rightful place" on the world stage. Ahmed al-Sharaa is the first Syrian leader to address the assembly since 1967. Last December, the former Islamist fighter headed a rebel alliance that overthrew the Assad regime. Twenty years ago, Sharaa was a devotee of al-Qaeda and detained in an Iraqi prison. As a leader of Islamist militants, the US Government put out a bounty of $10 million for his arrest.Also in the programme: A generic HIV drug for $40 US dollars per person per year; and from Adam Ant to Culture Club - a look back at London's influential Blitz Club of the 1980's.(Photo: Syrian President Ahmed al-Sharaa addresses the 80th United Nations General Assembly (UNGA) at the UN headquarters in New York, September 24, 2025. Credit: Reuters/Jeenah Moon)

German Chancellor Friedrich Merz introduces the 2026 budget with €126.7 billion in new investments for infrastructure, transport, schools, and other major projects. Leanna Byrne talks to a business industry leader in Berlin about why they're not happy with the proposals. And a deal has been reached to make a new HIV prevention drug much more affordable in low and middle income countries. You can contact us on WhatsApp or send us a voicenote: +44 330 678 3033.

Author and playwright James Magruder sits down with Ian Henzel to talk about his new short story collection "No One Is Looking at You". We dig into theater's collaboration vs. fiction's heavier lift, how alpha readers sharpen the work, and why ageism in publishing—especially for older LGBTQ voices—still needs naming. James gets personal about the moments that carved his voice (HIV survival, grief, joy), the journals that keep him honest, and the books that feel like home. In this episode • Stage craft → story craft: what changes (and what doesn't) • “Head always in a book”: military-brat roots & early influences • Rejection, resilience, and building with feedback (alpha readers) • Ageism in LGBTQ literature and widening the lens • Journals, voice, and the surprise of how readers respond • Favorite “worlds to live in” and why they stick Read a sample from "No One is Looking at You" → [https://www.book2look.com/book/yKG9CfMgjL Get the book → https://rattlinggoodyarns.com/product/no-one-is-looking-at-you/ #James Magruder #No One Is Looking at You #theater #fiction #ageism #literature #writing #influences #LGBTQ literature #storytelling

Fergie is ditched after her Epstein email leaks, Netflix's CEO opens up about Meghan, and Prince Harry warns of an HIV crisis.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In episode 57 of Going anti-Viral, Dawn Averitt joins host Dr Michael Saag to discuss HIV advocacy and the importance of scientific research. Ms Averitt is a social justice advocate and founder of organizations focused on women with HIV and AIDS such as the Well Project and the Women's Information Service and Exchange. Ms Averitt has served on several scientific and advisory committees, including 2 terms on the President's Advisory Council on HIV/AIDS, and has been responsible for key achievements in guiding FDA labeling decisions and shaping research and policy priorities at the NIH. Ms Averitt discusses being diagnosed with HIV at age 19 in 1988 and her experience with early treatment. She shares how this experience led her to the AIDS Survival Project and the Atlanta Buyers Project where she was an advocate for access to HIV care and treatment. Dr Saag and Ms Averitt discuss the current focus of HIV activism at a time when scientific research is threatened and the importance of today's HIV advocates to be a voice for research to the public at large.0:00 – Introduction1:17 – Ms Averitt's personal journey with HIV3:01 – How her treatment experience led to advocacy8:36 – Her role with the AIDS Survival Project and the Atlanta Buyers Club 17:12 – Current focus of HIV activism25:44 – How to persuade the public to support HIV and scientific research Resources:The Well Project: https://www.thewellproject.org/The Women's Research Initiative on HIV/AIDS (WRI): https://www.thewellproject.org/hiv-information/wri-2025-evolving-landscape-women-and-hiv-cure__________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

Class is in session, creeps! This week Karl & Vinnie dig through the bottom of the substitute bin to find out which fill-in “educator” deserves the title of "2nd creepiest substitute" behind Stuttering John of course.The score is currently Vinnie 4 - Karl 2 – Guest 4 visit thecreepoff.com to vote and decide this week's winnerCheck out this week's scum parade stories here: Auteur Is Arrested As "Rage Baiting" Video Scheme Backfires | The Smoking GunKey Largo man called roommate a ‘parasite,' tried to kill him with a crossbow – NBC 6 South FloridaFormer Lindale daycare worker pleads guilty to kicking toddlersRapist who recklessly spread HIV may have hundreds more victims, police fear | News UK | Metro NewsWant more of the madness? Support the show on Patreon, Supercast & Backed.by to snag exclusive merch and get an extra bonus episode every week!Don't forget you can leave us a voicemail at 585-371-8108Want to support the show? Find us on Patreon and Supercast to get exclusive merch an extra bonus episode every week! You can follow our Results girl Danni on Instagram @Danni_Desolation

Everyone Has A Status: The Fight To End HIV Despite decades of progress in treatment and prevention, HIV remains a challenge in America. Stigma continues to be a main barrier that keeps many from getting tested or staying in care. Our experts explain the history behind the harmful stigma and the innovative initiatives that will help end this epidemic. Do Americans Have A Prejudice Against Immigrant Doctors? Immigrant doctors are an important part of America's physician workforce, especially in rural and underserved communities. However, our expert warns that relying on foreign physicians is only a temporary fix for America's worsening doctor shortage, which may become devastatingly apparent with the changing immigration policies. Medical Notes: You're Taking Too Many Medications, Why Early Detection For Alzheimer's Disease Isn't Working, And A Better Treatment For Carbon Monoxide Poisoning Are you taking too many medications? Your blood may soon have tiny robots flowing through it. We can detect more cases of alzheimer's disease, so why aren't we? A new fix for carbon monoxide poisoning. Learn more about your ad choices. Visit megaphone.fm/adchoices

Despite decades of progress in treatment and prevention, HIV remains a challenge in America. Stigma continues to be a main barrier that keeps many from getting tested or staying in care. Our experts explain the history behind the harmful stigma and the innovative initiatives that will help end this epidemic. Learn More: https://radiohealthjournal.org/everyone-has-a-status-the-fight-to-end-hiv Learn more about your ad choices. Visit megaphone.fm/adchoices

È il 1986: un comitato scientifico internazionale stabilisce un nuovo nome per indicare il virus dell'Aids: d'ora in poi si parlerà soltanto di Hiv, ovvero “Virus dell'immunodeficienza umana”.  Nel corso della seconda conferenza mondiale sulla pandemia che si tiene a Parigi, l'OMS fornisce una stima dai 5 ai 10 milioni di sieropositivi, mentre i morti si contano già in alcune migliaia.  Non stupisce che, in un mondo in cui per telefonare fuori casa si usano ancora i gettoni, passi quasi inosservata ai più l'emergenza pandemica causata da C-brain, il primo virus informatico della storia.Ma a impressionare e a incutere timore e insicurezza nell'opinione pubblica mondiale, nel corso dell'anno concorrono anche altri eventi tragici e fatali: come l'esplosione avvenuta il 28 gennaio in diretta televisiva, nel corso della fase di decollo dello Space Shuttle Challenger, con il sacrificio di tutti e sette i componenti dell'equipaggio… eppure l'esplosione avvenuta il 26 aprile del reattore numero 4 della centrale atomica di Chernobyl, nell'Ucraina ancora sovietizzata, che libera una spaventosa nube tossica e radioattiva che si espanse nei cieli di tutta Europa.In questo episodio:La chiusura della Steps - Il PCI e la questione omosessuale - La mozione della CGIL sul movimento - L'inchiesta di Babilonia sugli omosessuali perseguitati dal fascismo - L'attentato a Ivan Teobaldelli - Il caso di Bruno Deiana - L'impegno di Lina Sotis nei confronti delle iniziative del movimento gay.Interviste a:Daniele Cassandro, giornalista e critico musicale; Franco Grillini, attivista, politico e giornalista, già segretario nazionale di Arcigay: Roberto Dartenuc, responsabile organizzativo Arcigay; Pietro Folena, politico e giornalista; Giovanni Dall'Orto, attivista, giornalista, storico; Ivan Teobaldelli, attivista, giornalista, scrittore, co-fondatore del mensile Babilonia; Enzo Cucco, attivista, giornalista e membro del Fuori!; Lina Sotis, giornalista e scrittrice.Per approfondire gli argomenti di questo episodio:BIBLIOGRAFIA:Fabio Giovannini, Comunisti e diversi - Il PCI e la questione omosessuale, Bari, Dedalo Libri, 1980COLONNA SONORA:On the beach - Chris ReaA kind of magic - QueenDon't leave me this way - The CommunardsCarovan of love - The HousemartinsIn between days - The CureVampirella - The SystemNotorius - Duran DuranTrue colors - Cyndy LauperWord up - CameoDon't dream it's over - Crowded HouseHanging on a heart attack - DeviceDriving satisfaction - Grace JonesTake my breath away - BerlinAdrenalina - Giuni Russo e Donatella RettoreLive to tell - MadonnaOh, l'amour - Erasure

This segment unpacks the potent intersection of queer identity, HIV stigma, and religious condemnation through a Pulitzer-winning musical. We explore how faith-based shame and societal neglect, especially during the AIDS crisis, weaponized pain against the LGBTQ+ community, leading to immeasurable loss and continued fear, even with life-saving medications. It's a stark reminder that bigotry costs lives, and that societal acceptance still lags behind medical progress, particularly for marginalized groups. When "morality" dictates who deserves care, humanity truly suffers.News Source: Black Gay Playwright Michael R. Jackson Talks HIV Stigma, PrEP, and the Tyler Perry Film Inside His Strange Loop By Darian Aaron for GLAAD August 13, 2025 

This week on the Hung Up Podcast, we sit down with Bebashi – Transition to Hope's CEO Sebrina Tate to unpack how one of Philadelphia's most vital community organizations is tackling HIV, food insecurity, and health disparities head-on. From leading the nation in viral suppression rates to feeding thousands through their FoodFirst Pantry, Bebashi is rewriting what culturally relevant community care looks like. Eric explores the blueprint that takes people from crisis to care—and ultimately, to hope. IG @philly.bebashi

Episode 203: Microinduction and harm reduction in OUD.  Nathan Bui and Sanjay Reddy describe how to manage opioid use disorder (OUD) by using microinduction and harm reduction, strategies that are reshaping the way we treat opioid use disorder. Written by Sanjay Reddy, OMSIV and Nathan Bui, OMSIV. Western University of Health Sciences, College of Osteopathic Medicine of the Pacific.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.IntroWelcome to episode 203 of Rio Bravo qWeek, your weekly dose of knowledge.Today, we're tackling one of the biggest health challenges of our time: opioid use disorder, or OUD. Nearly every community in America has been touched by it: families, friends, even healthcare providers themselves. For decades, treatment has been surrounded by barriers, painful withdrawals, stigma, and strict rules that often do more harm than good. Too many people who need help never make it past those walls. But here's the hopeful part, new approaches are rewriting the story. They are less about rigid rules and more about meeting people where they are. Two of the most promising strategies for treatment of OUD are buprenorphine microinduction and harm reduction. Let's learn why these two connected strategies could change the future of addiction recovery. Background information of treatment: The X-waiver (short for DATA 2000 waiver) was a special DEA requirement for prescribing buprenorphine for opioid use disorder. Doctors used to take extra training (8 hours) and apply for it. Then, they could prescribe buprenorphine to a very limited number of patients. The X-waiverhelped regulate buprenorphine but also created barriers to access treatment to OUD. It was eliminated in January 2023 and now all clinicians with a standard DEA registration no longer need a waiver to prescribe buprenorphine for OUD. Why buprenorphine?Buprenorphine is one of the safest and most effective medications for opioid use disorder. It has some key attributes that make it both therapeutic and extremely safe: 1) As a partial agonist at mu-opioid receptors, it binds and provides enough partial stimulation to prevent cravings and withdrawal symptoms without producing strong euphoria associated with full agonists. 2) Because it has a strong binding affinity compared to full agonists, it easily displaces other opioids that may be occupying the receptor. 3) As an antagonist at kappa-opioid receptors, it contributes to improved mood and reduced stress-induced cravings. 4) The “ceiling effect”: increasing the dosage past a certain point does not produce a stronger opioid effect. This ceiling effect reduces the risk of respiratory depression and overdose, making it a safer option than full agonists. 5) It also had mild analgesic effects, reducing pain. 6) Long duration of action: The strong binding affinity and slow dissociation from the mu-opioid receptor are responsible for buprenorphine's long half-life of 24–60 hours. This prolonged action allows for once-daily dosing in medication-assisted treatment for OUD. Induction vs microinduction:The problem is, starting it—what's called “induction”—can be really tough. Patients usually need to stop opioids and go through a period of withdrawal first. Drugs like fentanyl, which can cause precipitated withdrawal —a sudden, severe crash may push people back to using opioids. Because buprenorphine binds so tightly to the mu-opioid receptor, it can displace other opioids, such as heroin or methadone. If buprenorphine is taken while a person still has other opioids in their system, it can trigger sudden and severe withdrawal symptoms.Opioid withdrawal sign sand symptoms:Opioid withdrawal symptoms are very uncomfortable; patients may even get aggressive during withdrawals. As a provider, once you meet one of these patients you never forget how uncomfortable and nasty they can be. The symptoms are lacrimation or rhinorrhea, piloerection "goose flesh," myalgia, diarrhea, nausea/vomiting, pupillary dilation, photophobia, insomnia, autonomic hyperactivity (tachypnea, hyperreflexia, tachycardia, sweating, hypertension, hyperthermia), and yawning. Think about all the symptoms you run for COWS (Clinical Opiate Withdrawal Scale). It is estimated 85 % of opioid-using patients who inject drugs (PWID) reported opioid withdrawal. Fortunately, even though opioid withdrawal is very uncomfortable, it is not life-threatening (unlike alcohol or benzodiazepine withdrawal, which can be fatal).Many patients who start the journey treating opioid use disorder experience “bumps in the road” --they avoid treatment or drop out early. What is Microinduction? Microinduction is a fairly new strategy started in Switzerland around 2016. It is also known as the “Bernese method” (named after the city of Bern, Switzerland). With this method, instead of stopping opioids cold turkey, patients start with tiny doses of buprenorphine—fractions of a milligram. These doses gradually increase over several days while the patient continues their regular opioid use. While they begin this titer, they can continue use of the full agonist they were previously using–methadone, fentanyl, or heroin, while the buprenorphine begins to take effect. Once the buprenorphine builds up to a therapeutic level, the full agonist is stopped. This method uses buprenorphine's unique pharmacology to stabilize the brain's opioid system without triggering those really nasty withdrawal symptoms.Early studies and case reports suggest this is safe, tolerable, and effective method to do. Microinduction is changing the game, and it has been spreading quickly in North America. Instead of forcing patients to stop opioids completely, the dose is slowly increased over the next three to seven days, while the patient keeps using their usual opioids.By the end of that week, the buprenorphine has built up to a therapeutic level and the full agonist is stopped. The difference is really dramatic. Instead of a painful crash into withdrawal, patients describe the process as a gentle step down, or a ramp instead of a cliff. It's a flexible method. It can be done in a hospital, a clinic, or even outpatient with good follow-up. Once a patient and doctor develop a strong relationship built on the principles of patient autonomy and patient-centered care, microinduction can be closely monitored on a monthly basis including televisits. Microinduction has been shown to help more patients stay in treatment. The Role of Harm Reduction Instead of demanding perfection, harm reduction focuses on best practices providers can implement to reduce risk and keep patients safe. Harm reduction can vary from providing naloxone to reverse overdoses, giving out clean syringes, or offering safer injection education. It also means allowing patients to stay in treatment even if they keep using other substances, and tailoring care for groups like adolescents, parents, or people recently released from incarceration. Harm reduction says that instead of demanding perfection, let's focus on progress. Instead of all-or-nothing, let's devote resources to keeping people alive and safe. As mentioned,an option is providing naloxone kits so overdoses can be reversed in the moment. Also, giving out clean syringes so the risk of HIV or hepatitis infection is reduced while injecting heroin. Another way to reduce harm is teaching safer injection practices so people can protect themselves until they're ready for that next step in their treatment. It also means keeping the doors open, even when patients slip. If someone is still using other substances, they still deserve care. And it means tailoring support for groups who oftentimes get left behind. For people like adolescents, parents balancing childcare, or people coming out of incarceration who are at the highest risk of overdose. Harm reduction recognizes that recovery isn't a straight line. It's about meeting people where they are and walking with them forward. Conclusion:Microinduction is itself a harm reduction strategy. It lowers barriers by removing the need for painful withdrawal.When paired with a harm reduction culture in clinics, patients are more likely to enter care, stay engaged, and build trust with doctors for continued care. Managing opioid use disorder is one of the greatest health challenges of our time. But solutions like buprenorphine microinduction and harm reduction strategies are reshaping treatment—making it safer, more humane, and more accessible. If we embrace these approaches, we can turn barriers into bridges and help more people find recovery. Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you. Send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:Bluthenthal, R. N., Simpson, K., Ceasar, R. C., Zhao, J., Wenger, L., & Kral, A. H. (2020). Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs. Drug and Alcohol Dependence, volume 211, 1 June 2020, 107932. https://doi.org/10.1016/j.drugalcdep.2020.107932.De Aquino, J. P., Parida, S., & Sofuoglu, M. (2021). The pharmacology of buprenorphine microinduction for opioid use disorder. Clinical Drug Investigation, 41 (5), 425–436. https://doi.org/10.1007/s40261-021-01032-7. Taylor, J. L., Johnson, S., Cruz, R., Gray, J. R., Schiff, D., & Bagley, S. M. (2021). Integrating harm reduction into outpatient opioid use disorder treatment settings. Journal of General Internal Medicine, 36 (12), 3810–3819. https://doi.org/10.1007/s11606-021-06904-4.Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/. 

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, "Rethinking Parkinson's Care: Prevention, Equity, and Access to Treatment," Michael Okun, MD, neurologist, author of The Parkinson Plan, and medical advisor for the Parkinson's Foundation, discusses the urgent need for global access to levodopa, the gold-standard treatment for Parkinson disease. He outlines the consequences of delayed or unavailable treatment worldwide, including worsening outcomes and unnecessary disability. Okun highlights lessons from global HIV drug distribution that can inform equitable levodopa access, emphasizing the importance of tailoring strategies to local economies and healthcare systems. Additionally, he breaks down key components of The Parkinson Plan, including prevention, research priorities, amplifying patient and caregiver voices, and rethinking care models to better address the world's fastest growing neurodegenerative disorder. Finally, he explains how the book can serve as a resource not only for clinicians, but also for patients, families, and policymakers. Looking for more Movement disorders discussion? Check out the NeurologyLive® Movement disorders clinical focus page. Episode Breakdown: 1:00 – Consequences of delayed or unavailable levodopa treatment for patients worldwide 2:40 – How universal levodopa access could change care in low-resource settings 5:15 – Lessons from global HIV drug distribution for equitable levodopa delivery 7:00 – Neurology News Network 8:35 – Key pillars of The Parkinson Plan and rethinking Parkinson's care models The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: EMA Approves Semaglutide as First GLP-1 RA for Cardiovascular, Stroke-Related Benefits Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Since we're coming up on the last day of summer, it seems as good a time as any for ... a Wisconsin-made frozen pizza taste-off!The staff at Milwaukee Magazine took on that delicious task recently, so we start our episode with Ann sharing the surprising (and kinda disappointing???) results. She also keeps us in magazine land for her recent review of Las Gardenias, a new(ish) spot with homemade tortillas, birria and unique desserts.Elsewhere, we give you the scoop on a couple local food events, including the Dining Out For Life fundraiser happening through this weekend that supports Vivent Health's mission to serve those most affected by HIV. Just beyond this weekend, Potawatomi Casino Hotel has its Gather & Grow dinners, which span two nights (Sept. 22-23) and include five courses of farm-to-table goodies.Finally, we literally save the best for last with Milwaukee Magazine's "Best of Milwaukee" awards, which this year saw the publication's readers make some very savvy decisions about their food and restaurant choices. And by that we mean they mostly agreed with Ann.

In this episode of SHE MD, hosts Mary Alice Haney and Dr. Thaïs Aliabadi welcome Kendall Toole, former Peloton instructor and entrepreneur. Kendall shares her journey from struggling with mental health to becoming a fitness icon and an advocate for women's empowerment. This conversation covers topics ranging from personal growth to women's health. Kendall also discusses why she chose a Mirena IUD (levonorgestrel-releasing intrauterine system 52 mg) for herself. For full prescribing information, visit mirena-us.com/pi. Sponsor: Visit Mirena.com for more information Access more information about the podcast and additional expert health tips by visiting SHE MD Podcast.Kendall Toole's 5 Key Takeaways: 1. Advocate For Yourself: Take an active role in the decisions for your health, understand your body, your lifestyle and your goals. Make sure your voice is heard and communicate your priorities and needs. 2. Consult Your Healthcare Provider: Schedule a women's health appointment to discuss your needs and explore what options are available for you. You are your best advocate along with your healthcare provider.3. Educate Yourself: Knowledge is power. If you're interested in a Mirena IUD, visit mirena.com to learn more and access resources to help you prepare for your next appointment. 4. Check In With Yourself: You know yourself best but when things are feeling off, ask for help and lean on your support system. 5. Personal Fulfillment: Make sure you also take time to fill up your own cup, identify your core passions and dedicate yourself to pursuing them with authenticity and enthusiasm.INDICATIONS FOR MIRENAMirena® (levonorgestrel-releasing intrauterine system) is a hormone-releasing IUD that prevents pregnancy for up to 8 years. Mirena also treats heavy periods for up to 5 years in women who choose intrauterine contraception. IMPORTANT SAFETY INFORMATIONIf you have a pelvic or genital infection, get infections easily, or have certain cancers, don't use Mirena. Less than 1% of users get a serious pelvic infection called pelvic inflammatory disease (PID).If you have persistent pelvic or stomach pain, or excessive bleeding after placement, tell your healthcare provider (HCP). If Mirena comes out, call your HCP and avoid intercourse or use non-hormonal back-up birth control (such as condoms or spermicide). Mirena may go into or through the wall of the uterus and cause other problems.Pregnancy while using Mirena is uncommon but can be life threatening and may result in loss of pregnancy or fertility.Ovarian cysts may occur but usually disappear.Bleeding and spotting may increase in the first 3 to 6 months and remain irregular. Periods over time usually become shorter, lighter, or may stop. Mirena does not protect against HIV or STIs.Only you and your HCP can decide if Mirena is right for you. Mirena is available by prescription only.For important risk and use information about Mirena, please see Full Prescribing Information.In This Episode:00:00 Introduction05:03 Overcoming mental health and finding inner strength10:10 Kendall's women's health journey15:09 Choosing a Mirena IUD20:17 Planning for now and the future24:50 Understanding and using a Mirena IUD26:12 Kendall Toole's Advice to younger self29:26 Following passion leads to success RESOURCES: Kendall Toole InstagramKendall Toole TikTok Mirena GUEST BIOGRAPHY:KENDALL TOOLE is a lightning rod of energy, a natural-born fighter, dynamic athlete, and top fitness instructor who commands the room and empowers her community. With a background in performance and athletics, Kendall has been a multi-sport athlete, amateur boxer, and actress. She graduated from USC's prestigious School of Cinematic Arts and began her career in content production before discovering her passion for inspiring others, especially women, to step into their power.See Privacy Policy at https://art19.com/ privacy and California Privacy Notice at https://art19.com/privacy - do-not-sell-my-info. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This week, we're revisiting an episode where Marianna sat down with John Faragon to talk about post-exposure prophylaxis in pocket or PIP. Listen in to learn all about what it is, who it's for, and how it can help prevent HIV for more people.--  Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=AQX7941)--Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes. --Check out our free online courses: www.necaaetc.org/rise-courses--Download our HIV mobile apps:Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=USApple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691

Could Ozempic slow—or even reverse—aging? We take a closer look at the science behind the buzzy headlines.References:Semaglutide Slows Epigenetic Aging in People with HIV-associated lipohypertrophy: Evidence from a Randomized Controlled Trial | medRxiv  [pre-print]Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial - PubMedFind a full transcript here. New to Nutrition Diva? Check out our special Spotify playlist for a collection of the best episodes curated by our team and Monica herself! We've also curated some great playlists on specific episode topics including Staying Strong as We Age, Diabetes, Weight Loss That Lasts and Gut Health! Also, find a playlist of our bone health series, Stronger Bones at Every Age. Have a nutrition question? Send an email to nutrition@quickanddirtytips.com.Follow Nutrition Diva on Facebook and subscribe to the newsletter for more diet and nutrition tips. Find out about Monica's keynotes and other programs at WellnessWorksHere.comNutrition Diva is a part of the Quick and Dirty Tips podcast network. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Comedian Ken Reid (@kennethwreid) joins Jesse, Matt and Andy to talk about growing up a child of television, mud wrestling, Ken's podcast TV Guidance Counselor, an HIV prevention breakthrough, the insanity of Movie 43, the human washing machine no one asked for, blasting plastic waste with a plasma torch, Doja Cat's nod to Max Headroom, Ladies and Gentlemen, The Fabulous Stains, the reason plastic recycling mostly ended, Andy's Oktoberfest shows in Lake Arrowhead, John Williams polka music and bending ice to produce electricity.

Dr. Cory Russo is the Chief Medical Examiner Investigator of the Utah Office of the Medical Examiner (OME). This means she supervises all of the OME investigations for the entire state of Utah, which is an almost 85,000-mile area. She combines investigative medical, and legal skills to improve public health and also (Perhaps surprisingly!) to help the living.Dr. Russo manages a team of approximately 120 investigators who gather information for the medical examiner to use when determining the cause and manner of death. Her team is the first to get to the scene. Her job includes:  Going to the scene of the death to examine the scene, gather evidence, and take pictures. Talking with the deceased's friends and family to learn more about the deceased and what they experienced before their death. Gathering records such as medical or law enforcement recordsShe has immense experience in this field, both in education and on the job. She has a bachelor's and master's degrees in the fields of forensic science, psychology, medical health sciences, and business administration. Her doctorate is in medical health sciences from Eastern Virginia Medical School. She worked in hospital emergency departments and newborn intensive care units (NICUs); conducted research about HIV drug targets, child homicides, and suicide; and was a medical examiner investigator in multiple states.Send Julie a text!!Hey, thanks so much for listening to the podcast. I don't know if you know this, but I work with female small-business owners and entrepreneurs who are in a season of evolution and need help with their words, visuals, and story telling for their new direction! If that's you, send me a message at www.pivotzz.com or DM me on Instagram @shepivotzz------------------------------------------------------------------------------------------ I absolutely LOVE being the host and producer of "Women with Cool Jobs", where I interview women who have unique, trailblazing, and innovative careers. It has been such a blessing to share stories of incredible, inspiring women since I started in 2020. If you have benefitted from this work, or simply appreciate that I do it, please consider buying me a $5 coffee. ☕️ https://www.buymeacoffee.com/julieberman Thank you so much for supporting me -- whether by sharing an episode with a friend, attending a LIVE WWCJ event in Phoenix, connecting with me on Instagram @womencooljobs or LinkedIn, sending me a note on my website (www.womenwithcooljobs.com), or by buying me a coffee! It all means so much.

5—6—3—4—3—1—7—2In the first episode under our new podcast name (it's now the Science Fictions podcast!), we ask whatever happened to all those games that claimed to tell you your “brain age”—games that turned into a whole scientific literature on brain training. We discuss: the still-unresolved question of whether training one specific cognitive ability makes you generally smarter; seemingly endless contrasting meta-analyses; and the small matter of what brain training might tell us about the nature of intelligence.(If you can repeat the list of numbers from the top in reverse order then you have the brain of a 25-year-old. If you're 25 or younger, then I don't know what to tell you.)We're now an official part of the Works in Progress podcast world. You can find their other podcasts, including Hard Drugs, the one we talked about on today's episode (about the remarkable development of a drug for HIV), at podcast.worksinprogress.co. Show notes* The 2008 PNAS paper that started the craze for working memory training* The under-discussed rebuttal* 2013 meta-analysis concluding there's no evidence for far transfer* 2015 meta-analysis concluding there is no convincing evidence brain training is effective* 2016 meta-analysis saying there is no convincing evidence brain training is NOT effective* Very useful and detailed 2016 review of the evidence and the methodological issues inherent in brain training (including active vs. passive control groups)* 2020 meta-meta-analysis arguing that the active-passive distinction doesn't matter* 2023 review criticising the meta-meta-analysis* And the authors' own 2020 meta-analysis* 2022 meta-analysis of commercial brain training in older peopleCreditsThe Science Fictions podcast is produced by Julian Mayers at Yada Yada Productions. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit sciencefictionspod.substack.com/subscribe

In the Public Interest is excited to continue In That Case, its third annual miniseries examining notable decisions recently issued by the US Supreme Court. In this episode, host Felicia Ellsworth speaks with WilmerHale Partner Andrew Rhys Davies and Senior Attorney for the ACLU's National LGBTQ and HIV projects Josh Block about United States v. Skrmetti. The case considers whether a Tennessee state law banning gender-affirming medical care for transgender youth violates the Constitution's Equal Protection Clause.Davies and Block unpack the legal reasoning behind the Supreme Court's 6–3 ruling, including the international context highlighted in WilmerHale's amicus brief. Block also reflects on the decision's potential impact on future civil rights litigation and its immediate consequences for the transgender community and access to gender-affirming healthcare.

In the U.S., there are about 100,000 monkeys, baboons, and other primates living in captivity to support scientific research. About 5,000 of them are at OHSU’s Oregon National Primate Research Center. That’s where researchers do experiments on monkeys to try to get clear data about things like cannabis use during pregnancy, and to find cures for diseases like HIV. Animal rights activists have argued for decades that the center should be closed. And they’re gaining momentum with support from Oregon’s governor and some lawmakers. In addition, scientists who oppose using animals in research argue that the practice has become obsolete and is hindering, not helping the effort to find cures.    OPB health reporter Amelia Templeton recently visited the Oregon National Primate Research Center and talked to a lot of smart people on all sides of this complex topic. She joins us to share her reporting.    Don’t forget to check out our many podcasts, which can be found on any of your favorite podcast apps: Hush Timber Wars Season 2: Salmon Wars Politics Now Think Out Loud And many more! Check out our full show list here.

A move to fine families with children who are out past curfew is on hold for now at the City-County Council. The Marion County Public Health Department launched a new website where residents can request a free HIV test kit. Indiana food banks report growing concerns as food insecurity reaches its highest level in a decade. The future of sports is being shaped at the inaugural TEDSports event in Indianapolis. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org/news and follow us on social media to get comprehensive analysis and local news daily. Subscribe to WFYI News Now wherever you get your podcasts. WFYI News Now is produced by Zach Bundy and Abriana Herron, with support from News Director Sarah Neal-Estes.

We outside with another episode—breaking down the Cutwater blackout in a can, why folks been saying Denzel's name wrong, a wild UK ruling that bald = sexual harassment, and even talk of an alien mothership pulling up.Also on deck:​Uber going cash only ​McDonald's dropping $5–$8 meals​Young Thug's jail calls leaking to the streets​Fight game heavy: Jake Paul vs Tank Davis, Tyson vs Mayweather, Canelo vs Crawford rumors​Magic Johnson, HIV, and today's athletes​Breaking news on the Charlie Kirk assassination

HIV has been in retreat around the world. Fewer people are dying of the disease.New infections are decreasing. More HIV positive people have access to life saving medicine.Those trend lines have been moving in the right direction for decades. And US investment is one big reason.The Trump Administration dismantled foreign assistance through USAID, it continued PEPFAR — the President's Emergency Plan For AIDS Relief — but much of the work is either no longer happening or happening at a very reduced capacity.For decades, the United States led global efforts to end HIV/AIDS. That's no longer happening. Where will the trend lines go from here? For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at plus.npr.org. Email us at considerthis@npr.org.This episode was produced by Jeffrey Pierre. You also heard reporting in this episode from NPR's Gabrielle Emanuel from Zambia.It was edited by Courtney Dorning and Rebecca Davis.Our executive producer is Sami Yenigun.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Bio D-REK's Angels & Warriors was founded by Derek Canas, a long-term survivor who contracted HIV as a child through a blood transfusion following surgery for a congenital heart defect. Born with transposition of the great arteries, Derek underwent open-heart surgery as an infant and has lived with a pacemaker since he was a child. Now on his fifth device, he continues to navigate life with both HIV and chronic heart disease. Over the years, Derek's personal fight evolved into a broader mission. He became a passionate advocate. Not just for himself, but for others living with HIV whose stories are often left out of public awareness and policy conversations. Angels & Warriors was created to spotlight these realities, with a focus on communities that are routinely underrepresented: heterosexual individuals, serodiscordant couples, and long-term survivors. https://www.angelsandwarriors.org/about    

In this solo episode, Lindsey dives into the world of peptide injections, with a focus on the controversial “Wolverine shot” (BPC-157). She explores what peptides are, why they're trending in gyms, wellness clinics, and med spas, and how they're marketed for muscle gain, fat loss, recovery, and anti-aging.Lindsey discusses the science (and lack thereof), FDA concerns, and potential risks like overdosing, contamination, and unregulated use. She closes by reminding listeners that while peptides are intriguing, true health and longevity still come from foundational practices—quality sleep, nutrition, strength training, and meaningful human connection. Listen in to learn more : 01:03 – Why People Use PeptidesClaimed benefits include lean muscle gain, faster recovery, testosterone support, fat loss, and anti-aging. However, the evidence base is thin.01:18 – BPC-157 and Other PeptidesBPC-157: derived from stomach peptides, believed to speed up tissue healing and reduce inflammation.Tesamorelin: studied for HIV-related fat reduction.Sermorelin: targeted for sleep and recovery.CJC-1295 + Ipamorelin: growth hormone–related stacks are popular among bodybuilders.02:28 – Lack of Scientific EvidenceMost data comes from animal studies or small trials, not significant human clinical research.03:55 – FDA ConcernsThe FDA flagged four peptides in 2022; that number jumped to 26 by the end of 2023, showing rapid regulatory scrutiny.04:42 – Anecdotal Use by Doctors and CEOsSome report success with peptides like BPC-157 for injuries, but even they acknowledge the lack of robust science.05:35 – Risks of Overuse and ContaminationOverdosing risks: especially when combining peptides with testosterone, leading to organ enlargement.Contamination/mislabeling: Many peptides sold are unregulated, increasing health risks.06:15 – Back to Basics for LongevityDespite the hype, proven health strategies remain the same: sleep, exercise, protein, reducing sugar, strength training, and social connection.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-lindsey-elmore-show--5952903/support.